Facial Balancing: What the Evidence Says
Facial balancing is a frontal assessment of proportion and symmetry, and a plan drawn from it. It is not a procedure, and nothing is approved under that name. The proportions can be measured and a change can be recorded, which is the part with evidence behind it; how a face reads as a whole is a judgement rather than a measurement, which is the part that cannot be evidenced. This site is about the frontal view: thirds, fifths, width and the midline. The sagittal relationships between nose and chin on a true lateral view are a different assessment with different measurements, and they are treated separately. Risk grows with every zone that is treated, and that is the fact the category most often leaves out.
Chongqing West District Hospital, a tertiary general hospital in Jiulongpo District, Chongqing. This is a review of published evidence and regulation, not medical advice, and it is not a recommendation for or against any plan.
How claims are graded here
Every claim in this review sits in one of four groups. Established means the claim follows from something that can be measured or is reflected in regulation and labelling — that frontal proportions can be measured and recorded, that no face is symmetrical and none needs to be, and that the risk of injection grows with the number of zones treated, are all in this group. Limited means there is evidence and it is narrower than the claim made from it: that restoring volume in one zone changes the whole face, and that adding volume makes a face look smaller, sit here. Emerging means a signal without mature work. Not supported means the claim is made confidently and the evidence does not carry it, most often because the thing claimed is not measurable at all.
One structural distinction explains most of the grading. Proportions can be measured, and a change in them can be recorded, so claims about measurement belong to the first group. Whether the face reads as balanced, harmonious or natural is a judgement, and no validated instrument measures it, so claims about how a face reads belong to the last group however confidently they are made. The measurements are a real part of the assessment; they are not a decision procedure. Where the evidence is thin, this review says so, and where a claim rests on a convention rather than a measurement, it says that too.
How a balancing plan is regulated
There is no approved procedure called facial balancing, and no regulator has a category for it. What exists instead is a set of substances and devices, each approved for its own indication in its own jurisdiction: a hyaluronic acid filler approved for the correction of a specific facial area or a specific deficiency, a botulinum toxin product approved for a defined set of muscle-related indications, a device approved for a defined endpoint. A balancing plan is a selection from those, made for one person.
Three consequences follow. A claim about the plan as a whole cannot rest on approval, because no approval covers a plan, and page copy that implies one has moved from a fact about a product to a statement about a face without saying so. Each zone brings its own labelled risks, and those accumulate rather than averaging out, which is why a five-zone plan is not one treatment but five. And the aesthetic judgement — what balance means for this face — is not a regulated claim at all, because no regulator approves an appearance.
Where a page describes a balancing plan, this review reports what each substance in it is approved for, and then reports separately that the plan itself is a clinical judgement. That is not a criticism of planning. It is a description of the regulatory position, and it is the reason a reader should expect the reasoning behind each zone to be explained rather than assumed.
What the evidence establishes
These claims survive scrutiny. Each is stated with its own limit rather than as a general reassurance.
Frontal proportions can be measured and recorded
Established as an assessment. Vertical thirds, horizontal fifths, facial width relative to height and the position of the midline can all be described and recorded against photographs. What they cannot do is decide anything on their own: they are conventions for description, and a face that departs from them is not thereby a face that needs treatment.
No face is symmetrical, and none needs to be
Established. Measurable asymmetry is present in almost everyone, it is usually not noticed by the people who have it or by anyone else, and it is not a finding that requires correction. It becomes a clinical matter when it is pronounced, newly changed, or producing a functional problem, which are different questions from proportion.
Risk grows with every zone treated
Established, and labelled. Each injection site carries its own risks, and a plan that treats five zones has five sets of them. Bruising and swelling are near-universal; nodules, asymmetry, vascular occlusion and infection are less common and more serious. The risk does not average out across a plan, and the number of zones is the clearest predictor of it.
Volume and shape can be changed and the change recorded
Established for the substances involved, each on its own indication. Where a specific area is deficient, a filler approved for that area can change its contour, and the change can be photographed and compared. This is the part of the category with the most behind it, and it is a statement about a specific area rather than about the face as a whole.
Assessment at rest and in movement changes a plan
Established as a principle. A face that is symmetric at rest may not be in movement, and treating only the static photograph can produce a result that reads oddly when the person talks or smiles. Movement is part of the assessment, and a plan that has not considered it has assessed a photograph rather than a face.
Claims the evidence does not carry
These claims are common, and none of them is supported. Naming them is the most useful thing this review does.
That facial balancing is a single procedure
Not supported. There is no procedure of that name and nothing approved under it. What is called a balancing plan is a selection of separately approved treatments, each with its own indication, its own risks and its own recovery. Describing the plan as one procedure makes it sound like a single decision with a single risk profile, which is exactly what it is not.
That proportion alone decides an outcome
Not supported. Proportions can be measured and they can be brought closer to a convention, and whether the face then reads as better is a separate judgement that no measurement settles. Faces that depart considerably from the classical proportions can read as more attractive than faces that match them, which is a well-observed fact and a fatal one for any claim that the numbers decide.
That filler can change the underlying bone
Not supported. A filler placed in soft tissue adds volume to soft tissue. It does not reshape bone, and no product is approved to. Where a plan is described as restoring skeletal support, the description has moved from what the substance does to a structural claim that no evidence supports and no approval covers.
That the whole face changes when one zone is treated
Limited at best. Treating one area can change how the face reads, because the eye compares features rather than judging them separately. That is a real perceptual effect. What is not established is that it is predictable, that it is large, or that it can be planned for in advance, which is why the claim is graded as limited rather than as a finding.
That a balanced face is a measurable target
Not supported. Balance is an aesthetic judgement made by an observer and by the person, and no validated instrument measures it. A plan can be described in terms of proportions, which is legitimate, and presenting it as the pursuit of a measurable target implies a precision the assessment does not have.
What the risks are, stated plainly
The first risk is built into the structure of the category. A balancing plan treats several zones, and each zone adds its own risks without any of them being reduced by the presence of the others. A plan described as a single treatment hides that arithmetic, and a reader who accepts the plan without knowing how many zones it contains has not been told the most important fact about its risk.
The clinical risks are the labelled ones, multiplied by the number of sites. Bruising and swelling are near-universal and settle. Nodules and lumps can form and may need treatment. Asymmetry can result and may be more noticeable than the asymmetry being corrected. Infection can follow any injection that breaks the skin. Vascular occlusion is rare and serious: filler entering a vessel can block the blood supply to skin or, in the worst case, to the retina, and the consequences can be permanent. That risk is small per injection and it accumulates over injections, which is why the number of zones is a risk fact rather than a cosmetic preference.
There are limits on the evidence, and they belong in this list because they shape what can be claimed. Balance and harmony are not measurable, so the outcome the category is named for cannot be assessed with an instrument, and studies that report improvement rely on observer ratings which vary in their reliability. Follow-up is often short relative to how long a filler lasts, so what is known about how a plan reads at two years is limited. And a plan that treats several areas has an attribution problem on top of its risk arithmetic: if the result is not what the person wanted, it is harder to say which zone produced it and therefore harder to correct.
What else is on the table, including doing nothing
The alternatives begin with treating one finding and leaving the rest alone, and that is where most plans should start. A face with several features that could each be changed does not require all of them to be changed, and a single well-chosen treatment addresses the finding that matters to the person while leaving the risk arithmetic at one zone instead of five. Where there is no specific finding, doing nothing is the honest option, because an assessment organised around a category is being applied to a face that has no named problem.
Waiting is a real alternative for a change that is not settled. A finding that has appeared recently may be swelling, a medication effect or a temporary change, and assessing it before it settles can lead to treating something that would have resolved. Time is also what makes an assessment possible: a photograph taken now and another in six months shows whether anything is actually changing, which is information no single visit produces.
Where the change is structural rather than soft tissue — a jaw relationship, a chin that is genuinely recessed relative to the profile, a nose whose dorsal line is the finding — the alternatives are surgical and the assessment is different, because the view being judged is different. Where the goal is skin quality rather than contour, the options are the ones described on the device and topical guides in this cluster. Which of these applies is an individual clinical question, and this review does not answer it for anyone.
How this review is kept current
This subject moves on two clocks. The evidence moves slowly, because the substances involved are well characterised and the studies that would settle the perceptual questions are difficult to design and rarely run. The vocabulary moves quickly, because a plan is easier to describe with a word such as balance than with a list of specific changes, and the word has been applied to an increasing range of treatments without any of them acquiring evidence for it.
This review is therefore dated and reviewed on a short cycle, and the review covers three things. The first is whether any claim has moved between the grading groups, in either direction, because a claim can become supported as well as cease to be. The second is regulatory status, since an approval, a restriction or a change to what a product may claim is a checkable fact that readers are entitled to have current. The third is whether the evidence base has changed in kind: another series of treated cases is a different event from a study with a validated outcome measure and blinded assessment, and only the second can settle the question this site is about.
Where this review is wrong, the correction is made to the page rather than noted somewhere else, and the date of the most recent review is shown on every page. Where a question is genuinely unresolved, this review states that it is unresolved rather than resolving it by tone. That is a deliberate editorial position: a reader who is told that the answer is not yet known can weigh the uncertainty, and a reader who is given false confidence cannot.
Facial balancing: the frontal proportions, and which claims hold
Every row is a claim you are likely to meet, placed against what the evidence supports and what regulators have actually approved. Evidence and regulatory status are two separate columns because they answer two separate questions.
The evidence guides
Each guide answers one question about the claim rather than about a treatment. Read the two or three that match what you are trying to establish.
What Facial Balancing Means in Practice
A frontal assessment of proportion and symmetry and a plan drawn from it. It is not a procedure, and nothing is approved under that name.
Read the guide →The Frontal Proportions, and How They Are Actually Read
Thirds, fifths, width and the midline: what each measurement contributes to an assessment, and what none of them can decide on its own.
Read the guide →Why Facial Balancing Is Being Offered More Often
An assessment language that sounds objective, applied to a decision that remains a judgement about a face. What the language adds and what it hides.
Read the guide →Regulatory Status: How a Balancing Plan Is Regulated
There is no approved procedure called facial balancing. Each substance and device in the plan carries its own approval, and the plan is a clinical judgement.
Read the guide →What the Evidence Supports About Changing Facial Proportions
Volume and shape can be changed and the change recorded. How the change reads is a separate question, and it is the one with the least evidence.
Read the guide →What Is Not Established About Facial Balancing
That it is a procedure, that proportion alone decides an outcome, and that filler changes anything beneath the skin: claims the evidence does not carry.
Read the guide →A question about the proportion evidence?
This site is an evidence review rather than a booking page, and it does not recommend for or against any plan or offer an assessment in relation to anything it describes. If you have a question about this review, or about what the evidence does and does not cover, contact the team and ask.
Frequently asked questions
Is facial balancing a procedure?
No, and nothing is approved under that name. It is a frontal assessment of proportion and symmetry together with a plan drawn from it. The plan is a selection of separately approved treatments, each with its own indication, risks and recovery, which is why describing it as one procedure hides the risk arithmetic that matters most.
What can the frontal proportions actually decide?
They can describe a face and record a change. Vertical thirds, horizontal fifths, width and the midline are conventions for description, and a face that departs from them is not thereby a face that needs treatment. Whether the face reads as better after a change is a judgement no measurement settles, and faces departing considerably from the classical proportions can read as more attractive than faces that match them.
How does facial balancing differ from profile balancing?
They are different views with different measurements. Facial balancing reads the frontal view: thirds, fifths, width and the midline. Profile balancing reads the sagittal relationships on a true lateral view, where the nose and chin are judged against each other. Different views, different measurements, different interventions, and a plan assessed on one view may not be the plan the other view calls for.
Does adding volume make a face look smaller?
It is graded as limited. Adding volume to a hollow can change how the face reads, because the eye compares features rather than judging them separately, and the effect is real for some people. What is not established is that it is predictable, that it is large, or that it can be planned for in advance, which is why it is not treated here as a finding.
Can filler change the bone underneath?
No. A filler placed in soft tissue adds volume to soft tissue, and it does not reshape bone. No product is approved to change bone. Where a plan is described as restoring skeletal support, the description has moved from what the substance does to a structural claim that neither the evidence nor any approval covers.
Why does the number of zones matter so much?
Because each zone carries its own labelled risks and they accumulate rather than averaging out. Bruising and swelling are near-universal, nodules and infection are less common, and vascular occlusion is rare and potentially serious. A plan treating five zones is five sets of risks, and the number of zones is the clearest single predictor of the risk a plan carries.
Part of Facial Shape — 7 sites on this topic